Clinical Trials Browser

Phase 2 × INDUSTRY × GIST × Clear all

NCT00618319 2015-10-02

An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)

Phase 2 Completed

GIST